Prognosis and Course of COVID-19 Infection in Hospitalised Patients
NCT04752085 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 345
Last updated 2023-01-26
Summary
The aim of the cohort prospective observational study is to define the major factors influencing the course of COVID-19 infections and its prognosis in hospitalised patients.
The investigators plan to include 300 patients hospitalised with COVID-19 infection.
The phone contacts with patients are due after 90 and 180 days after discharge.
Conditions
- Covid19
- SARS-CoV Infection
Interventions
- DIAGNOSTIC_TEST
-
Chitotriosidase activity
The chitotriosidase activity will be measured in all the subjects
Sponsors & Collaborators
-
I.M. Sechenov First Moscow State Medical University
lead OTHER
Principal Investigators
-
Olga Mironova, PhD · Sechenov University
-
Ekaterina Schelkanovtseva, MD · Sechenov University
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2020-11-01
- Primary Completion
- 2021-03-01
- Completion
- 2023-01-10
Countries
- Russia
Study Locations
More Related Trials
-
Prospective Hospital Registry of Patients With Suspected or Confirmed Coronavirus Infection (COVID-19) and Community-acquired Pneumonia
NCT04522076 ·Status: ACTIVE_NOT_RECRUITING
-
Bacterial and Fungal Microbiota of Patients With Severe Viral Pneumonia With COVID-19
NCT04359706 ·Status: COMPLETED
-
Caracterisation of COVID-19 Patients Hospitalized in Infectious Disease Department
NCT04779021 ·Status: UNKNOWN
-
Factors Associated With Clinical Outcomes in Patients Hospitalized for Covid-19 in GHT-93 Est
NCT04366206 ·Status: UNKNOWN
-
A Retrospective Study in Patients With Mild to Moderate COVID-19
NCT05374772 ·Status: UNKNOWN
-
Pandemic Triage Score in Patients With Known or Suspected Severe Acute Respiratory Syndrome (SARS) CoronaVirus (CoV) 2 Infection
NCT04371471 ·Status: COMPLETED
-
Analysis of Laboratory Markers for Severe COVID-19
NCT06460753 ·Status: COMPLETED
-
Covid-19 Associated Coagulopathy Predicted by Thrombodynamic Markers (CoViTro-I)
NCT05330832 ·Status: UNKNOWN
-
Risk Factors Worsening COVID19 for Out-patient With Home Monitoring
NCT04380662 ·Status: UNKNOWN
-
A Study Evaluating the Efficacy and Safety of CKD-314 (Nafabelltan) in Hospitalized Adult Patients Diagnosed With COVID-19 Pneumonia
NCT04623021 ·Status: COMPLETED ·Phase: PHASE2
-
Host-pathogen Interactions During SARS-CoV-2 Infection
NCT04376476 ·Status: COMPLETED ·Phase: NA
-
Defining COVID-19 Infection Severity on Presentation to Hospital
NCT05677789 ·Status: UNKNOWN
-
Validation of Prognostic Clinical Risk Scores in Predicting Outcome for Patients With COVID-19 at Initial Triage
NCT05582382 ·Status: UNKNOWN
-
Survey of COVID-19 Infection
NCT05706064 ·Status: COMPLETED
-
An International Observational Study of Adults With Acute Infection
NCT07069400 ·Status: RECRUITING
-
Education of Medical Staff to Post Acute Covid susTained sYmptoms
NCT06082258 ·Status: NOT_YET_RECRUITING ·Phase: NA
-
COVID-Like Illness Respiratory Pathogens. A Prospective Cohort on the COVID-19 Post-acute Condition
NCT05047666 ·Status: UNKNOWN
-
Protein Electrophoresis as a Tool for Complications Prediction in COVID-19 Hospitalised Patients
NCT04414059 ·Status: COMPLETED
-
Corona Virus Disease 2019 Patients Whose Nucleic Acids Changed From Negative to Positive
NCT04333589 ·Status: UNKNOWN ·Phase: NA
-
LDCT in COVID-19 Pneumonia: a Prospective Moscow Study
NCT04379531 ·Status: COMPLETED ·Phase: NA
-
Usefulness of C-reactive Protein Testing in Acute Cough
NCT01794819 ·Status: COMPLETED ·Phase: NA
-
Cohort Multiple Randomized Controlled Trials Open-label of Immune Modulatory Drugs and Other Treatments in COVID-19 Patients
NCT04324047 ·Status: UNKNOWN
-
Proxalutamide Treatment for Hospitalized COVID-19 Patients
NCT04728802 ·Status: COMPLETED ·Phase: PHASE3
-
Long-term Effects of COVID-19: a Comparative Cohort Study
NCT05002205 ·Status: UNKNOWN
-
Predictors of COVID-19 Infection and Disease Progression
NCT04484597 ·Status: UNKNOWN